Joel Greenblatt Rhythm Pharmaceuticals, Inc. Transaction History
Gotham Asset Management, LLC
- $10.2 Billion
- Q4 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 6,786 shares of RYTM stock, worth $345,882. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,786
Previous 9,471
28.35%
Holding current value
$345,882
Previous $496,000
23.59%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RYTM
# of Institutions
216Shares Held
64.4MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$344 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$335 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$310 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$310 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$188 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $2.84B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...